Literature DB >> 299684

Possible causes of complications of myelography with water-soluble contrast medium.

D G Potts1, D G Gomez, G F Abbott.   

Abstract

The mechanisms of CSF formation and absorption have been reviewed. The conditions that alter the rate of CSF formation and absorption may change the concentration of contrast in the cranial cisterns and the rate of passage through the cisterns. The significance of these alterations in relation to the complications of myelography with water-soluble contrast media is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299684

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN: 0365-5954


  7 in total

1.  Intrathecal injection of high-dose meglumine amidotrizoate with complete recovery.

Authors:  K Maruyama; Y Setoguchi; J Maruyama; T Shimizu; H Chikusa; M Takeuchi; Y Ogihara; M Muneyuki
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

2.  Is there an increased risk of early side effects of metrizamide in post-myelogram computed tomography?

Authors:  Y L Yu; G H du Boulay
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

3.  Experiences with intrathecally enhanced computed tomography.

Authors:  B Hammer
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

4.  Passage of Amipaque (metrizamide) through the arachnoid granulations.

Authors:  B C Lee; D G Gomez; D G Potts; A M Pavese
Journal:  Neuroradiology       Date:  1979-04-26       Impact factor: 2.804

5.  Adverse side effects of metrizamide in myelography.

Authors:  H J Gelmers
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

6.  Absorption of a non-ionic contrast agent from cerebrospinal fluid to blood.

Authors:  K Golman; I Wiik; S Salvesen
Journal:  Neuroradiology       Date:  1979-12-12       Impact factor: 2.804

7.  Subacute reactions to intrathecal amipaque (metrizamide), conray and dimer X: a structural and ultrastructural study.

Authors:  B C Lee; D G Gomez; D G Potts; A M Pavese
Journal:  Neuroradiology       Date:  1981-01       Impact factor: 2.804

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.